(S)-3,5-DICHLORO-N-((1-((2,2-DIMETHYLTETRAHYDRO-2H-PYRAN-4-YL)METHYL)-4-FLUOROPIPERIDIN-4-YL)METHYL)BENZAMIDE

Names

[ CAS No. ]:
1072018-68-8

[ Name ]:
(S)-3,5-DICHLORO-N-((1-((2,2-DIMETHYLTETRAHYDRO-2H-PYRAN-4-YL)METHYL)-4-FLUOROPIPERIDIN-4-YL)METHYL)BENZAMIDE

[Synonym ]:
(S)-3,5-dichloro-N-[1-(2,2-dimethyl-tetrahydro-pyran-4-ylmethyl)-4-fluoro-piperidin-4-ylmethyl]-benzamide
Benzamide,3,5-dichloro-N-[[4-fluoro-1-[[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]methyl]-4-piperidinyl]methyl]
(S)-3,5-Dichloro-N-((1-((2,2-dimethyltetrahydro-2H-pyran-4-yl)methyl)-4-fluoropiperidin-4-yl)methyl)benzamide

Biological Activity

[Description]:

T-Type calcium channel inhibitor is a potent inhibitor of T-Type calcium channel. T-Type calcium channel inhibitor penetrates well the CNS and blocks the native T-type currents in deep cerebellar nuclear neurons, the window current is completely abolished both for wild-type and mutant Cav3.1 channels. T-Type calcium channel inhibitor has the potential for the research of neurology disease[1].

[Related Catalog]:

Signaling Pathways >> Membrane Transporter/Ion Channel >> Calcium Channel

Research Areas >> Neurological Disease

[References]

[1]. Chemin J, et al. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene. Brain. 2018;141(7):1998-2013.

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₁H₂₉Cl₂FN₂O₂

[ Molecular Weight ]:
431.37200

[ Exact Mass ]:
430.15900

[ PSA ]:
41.57000

[ LogP ]:
5.06130

Safety Information

[ HS Code ]:
2934999090

Customs

[ HS Code ]: 2934999090

[ Summary ]:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%